Literature DB >> 7092626

Amitriptyline in the management of progressive supranuclear palsy.

J N Kvale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7092626     DOI： 10.1001/archneur.1982.00510180065029

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  3 in total

1.  Treatment of progressive supranuclear palsy with methysergide. A clinical study.

Authors:  G Di Trapani; P Stampatore; A La Cara; A Azzoni; M L Vaccario
Journal:  Ital J Neurol Sci       Date:  1991-04

Review 2.  Progressive supranuclear palsy: clinical features, pathophysiology and management.

Authors:  A Rajput; A H Rajput
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

3.  [Progressive supranuclear palsy: living environment of the patients in Germany].

Authors:  M Hensler; S Paul; C Abright; S Lorenzl
Journal:  Nervenarzt       Date:  2011-02       Impact factor: 1.214
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.